The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NF-
κΒ
2 SNPs, rs7897947, and rs12769316 and survival outcome of NSCLC patients.
 
Fotinos-Ioannis D. Dimtrakopoulos
No Relationships to Disclose
 
Anna G Antonacopoulou
No Relationships to Disclose
 
Anastasia E Kottorou
No Relationships to Disclose
 
Stella Maroussi
No Relationships to Disclose
 
Nikolaos Panagopoulos
No Relationships to Disclose
 
Ioulia Koukourikou
No Relationships to Disclose
 
Chrisoula D Scopa
No Relationships to Disclose
 
Thomas Makatsoris
Honoraria - Amgen; Merck; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche
 
Helen Papadaki
No Relationships to Disclose
 
Dimitrios Dougenis
No Relationships to Disclose
 
Haralabos Kalofonos
Consulting or Advisory Role - Amgen; Amgen (Inst); Genesis Pharmaceuticals; Genesis Pharmaceuticals (Inst); Janssen; Janssen (Inst); LEO Pharma; LEO Pharma (Inst); Lilly; Lilly (Inst); Merck; Merck (Inst); Merck Serono; Merck Serono (Inst); MSD; MSD (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Roche; Roche (Inst)
Research Funding - Amgen; Amgen (Inst); Bayer; Bayer (Inst); Genesis Pharmaceuticals; Genesis Pharmaceuticals (Inst); Janssen; Janssen (Inst); Lilly; Lilly (Inst); Merck Serono; Merck Serono (Inst); MSD; MSD (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Roche; Roche (Inst)
Travel, Accommodations, Expenses - Enorasis Pharmaceuticals; Novartis; Pfizer; Roche